SUNCT syndrome: priming of symptomatic periods and worsening of symptoms by treatment with calcium channel blockers.
We report a SUNCT patient who showed both a precipitation and worsening of symptomatic periods after treatment with L-type calcium channel blockers. This pharmacological response may provide us with important clues for understanding the pathophysiology of SUNCT, and hopefully to find a remedy for the victims of this syndrome. This observation could also support a verapamil trial in SUNCT patients as a precipitating of attacks.
Jiménez-Huete
A
A
Servicio de Neurología, Hospital Ruber Internacional, Madrid, Spain. ajimenezhu@nexo.es
Franch
O
O
Pareja
J A
JA
D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D003027:Cluster Headache / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D008297:Male; D013577:Syndrome
D002121:Calcium Channel Blockers